Etiqueta de registo: 00519cam 2200193 450
001 1742540
003 http://id.bnportugal.gov.pt/bib/porbase/1742540
005 20030623191800.0
035 ## $893708
095 ## $aPTBN01021486
100 ## $a19960830d1985 k y0pory0103 ba
101 0# $apor
102 ## $aBR
200 1# $aScribo$epoemas$fCélia Monte
210 ## $aSantos$c[s.n.],$d1985
215 ## $a117 p.
675 ## $a869.0(81)$vmed$zfre$3288321
700 #1 $aMonte,$bCélia,$f1942-$3805299
801 #0 $aPT$bBN$gRPC
977 ## $1869.0 SCR 1$2coop$4ULSD$6efalt316011$7bc$8coop$9ULSD$aDep.$b1615/96$k0
998 ## $aLSD53-257

Etiqueta de registo: 00780cam 2200217 450
001 1926108
003 http://id.bnportugal.gov.pt/bib/porbase/1926108
005 20030522160800.0
010 ## $a84-398-6152-4
035 ## $555279
095 ## $aPTBN00760313
100 ## $a19950323d1986 k y0pory0103 ba
101 0# $aeng
102 ## $aES
200 1# $aImmunomodulators$ecurrent problems in testing and evaluation of experimental and clinical effects of immunomodulators$fed.lit. Karel Masek
210 ## $aBarcelona$cJ.R.Prous Science,$d1986
215 ## $aVIII, 197 p.$d24 cm
300 ## $aProceedings of Symposoium sponsored by the International Society of Immunopharmacology, Pragas, May 12-14, 1985
675 ## $a612.017$3307284
702 #1 $aMasek,$bKarel$4340$3601289
801 #0 $aPT$bBN$gRPC
977 ## $1340C-04$2coop$4ULFA$6mq889353$7bc$8coop$9ULFA$b9802$k0
998 ## $aLFA6-86

Etiqueta de registo: 00782cam 2200229 450
001 1926105
003 http://id.bnportugal.gov.pt/bib/porbase/1926105
005 20030510152100.0
035 ## $354425
095 ## $aPTBN00377760
100 ## $a19880829d1975 km y0pory0103 ba
101 1# $aspa$cita
102 ## $aES
200 1# $aDesenho electrotécnico e electromecânico$epara técnicos, engenheiros, estudantes de engenharia e Tecnologia Superior...
210 ## $aSäo Paulo$cHemus,$d1975
215 ## $aIX, 511 p.$cil
300 ## $aInclui normas UNI, CEI, UNEL, ISO e suas correlações com as da ABNT
675 ## $a621.316.31$vmed$zfre$31413694
700 #1 $aDel Monaco,$bGino$31511831
701 #1 $aRé,$bVittorio$4070$3545609
702 #1 $aBini,$bEdson$4730$3128044
801 #0 $aPT$bBN$gRPC
977 ## $1621.316.31 MON Des$2coop$4ESTGFR$6mq569404$7bc$8coop$9ESTGFR$b362/88$k0
998 ## $aESTG1-263

Etiqueta de registo: 00572cam 2200205 450
001 1926103
003 http://id.bnportugal.gov.pt/bib/porbase/1926103
005 20030510152100.0
010 ## $a0-07-096551x
035 ## $354426
095 ## $aPTBN00377761
100 ## $a19880829d1986 km y0pory0103 ba
101 0# $aeng
102 ## $aIN
200 1# $aComputer techniques in power system analysis
210 ## $aNew Delhi$cTata McGraw Hill,$d1986
215 ## $aXII, 219 p.
675 ## $a621.314/.8$vmed$zfre$3494697
700 #1 $aPai,$bM. A.$3494698
801 #0 $aPT$bBN$gRPC
977 ## $1621.314/8 PAI Com$2coop$4ESTGFR$6mq569405$7bc$8coop$9ESTGFR$b363/88$k0
998 ## $aESTG1-264

Etiqueta de registo: 00799cam 2200241 450
001 1926100
003 http://id.bnportugal.gov.pt/bib/porbase/1926100
005 20030522160800.0
010 ## $a0-8247-7363-2
035 ## $555283
095 ## $aPTBN00760317
100 ## $a19950324d1985 k y0pory0103 ba
101 0# $aeng
102 ## $aUS
200 1# $aPercutaneous absorption$emechanisms, methodology, drug delivery$fed.lit. Robert L. Bronaugh, Howard I. Maibach
210 ## $aNew York$cMarcel Dekker,$d1985
215 ## $aXVI, 579 p.$d24 cm
225 2# $aDermatology$v6
300 ## $aSymposium held April 27, 1983 at Food and Drug Administration in Washington
675 ## $a615.015.4+616.5$31511827
702 #1 $aBronaugh,$bRobert L.$4340$3601295
702 #1 $aMaibach,$bHoward I.$4340$3522266
801 #0 $aPT$bBN$gRPC
977 ## $1330C-02-T$2coop$4ULFA$6mq889357$7bc$8coop$9ULFA$b9813$k0
998 ## $aLFA6-92

Etiqueta de registo: 00651cam 02200205 04500
001 1982062
003 http://id.bnportugal.gov.pt/bib/porbase/1982062
005 20030519135400.0
035 ## $495190
095 ## $aPTBN00698018
100 ## $a19800123d19 m y0pory0103 ba
101 1# $aspa
102 ## $aES
200 1# $aTu alma y la ajena$e<una >psicología práctica para todos$fRichard Muller-Freienfels$gtrad. A. Vallejo Nágera
210 ## $aBarcelona$cLabor,$d[19--]
215 ## $aXI, 459 p.$cil.$d23 cm
675 ## $a159.9$vmed$zfre$3288013
700 #1 $aMuller-Freienfels,$bRichard$3180443
702 #1 $aVallejo Nágera,$bA.$4730$3180444
801 #0 $aPT$bBN$gRPC
977 ## $1159.9 MUL$2coop$4ESEL$6mq797965$7bc$8coop$9ESEL$b13342$k0
998 ## $aEEL9-270